These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16291423)

  • 21. Long-term Outcomes of Induction Carboplatin and Gemcitabine Followed by Concurrent Radiotherapy With Low-dose Paclitaxel and Gemcitabine for Stage III Non-small-cell Lung Cancer.
    Guilbault C; Garant A; Faria S; Owen S; Ofiara L; Duclos M; Hirsh V; Kopek N
    Clin Lung Cancer; 2017 Sep; 18(5):565-571. PubMed ID: 28344046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of the unresectable non small cell lung carcinoma].
    Spásová I
    Cas Lek Cesk; 2005; 144(9):602-12; discussion 612-3. PubMed ID: 16193938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemoradiation in NSCLC: focus on the role of gemcitabine.
    Choy H
    Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):38-42. PubMed ID: 15339058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrating concurrent navelbine and cisplatin to hyperfractionated radiotherapy in locally advanced non-small cell lung cancer patients treated with induction and consolidation chemotherapy: feasibility and activity results.
    Reguart N; Viñolas N; Casas F; Gimferrer JM; Agustí C; Molina R; Martin-Richard M; Sanchez-Reyes A; Gascón P
    Lung Cancer; 2004 Jul; 45(1):67-75. PubMed ID: 15196736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimizing chemoradiation in locally advanced non-small-cell lung cancer.
    Curran WJ; Choy H
    Oncology (Williston Park); 2001 Mar; 15(3 Suppl 6):43-5. PubMed ID: 11301848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: mature results of the Spanish Lung Cancer Group 0008 study.
    Garrido P; Rosell R; Arellano A; Andreu F; Dómine M; Perez-Casas A; Cardenal F; Arnaiz Mdel M; Morán T; Morera R; Isla D; Valencia J; Cobo M; Delgado R; García-Gómez R; Calvo F; Zamora J; Ramos A; Massutí B
    Lung Cancer; 2013 Jul; 81(1):84-90. PubMed ID: 23611405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gemcitabine in non-small cell lung cancer.
    Crinò L; Cappuzzo F
    Expert Opin Pharmacother; 2002 Jun; 3(6):745-53. PubMed ID: 12036414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase III randomised study comparing concomitant radiochemotherapy as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancer.
    Berghmans T; Van Houtte P; Paesmans M; Giner V; Lecomte J; Koumakis G; Richez M; Holbrechts S; Roelandts M; Meert AP; Alard S; Leclercq N; Sculier JP
    Lung Cancer; 2009 May; 64(2):187-93. PubMed ID: 18804894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase II, open-label trial of bortezomib (VELCADE(®)) in combination with gemcitabine and cisplatin in patients with locally advanced or metastatic non-small cell lung cancer.
    Kontopodis E; Kotsakis A; Kentepozidis N; Syrigos K; Ziras N; Moutsos M; Filippa G; Mala A; Vamvakas L; Mavroudis D; Georgoulias V; Agelaki S
    Cancer Chemother Pharmacol; 2016 May; 77(5):949-56. PubMed ID: 26994909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy in locally advanced non-small cell lung cancer.
    Hamouda W; Dorgham Y; Yosry A; Abdel Wahab M
    Gulf J Oncolog; 2007 Jul; (2):55-64. PubMed ID: 20084725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
    de Castria TB; da Silva EM; Gois AF; Riera R
    Cochrane Database Syst Rev; 2013 Aug; (8):CD009256. PubMed ID: 23949842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of gemcitabine and carboplatin in the treatment of non-small-cell lung cancer.
    Cullen M
    Lung Cancer; 2005 Oct; 50 Suppl 1():S5-7. PubMed ID: 16291432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gemcitabine (Gemzar)-based induction chemotherapy in non-small-cell lung cancer.
    Scagliotti GV; Novello S
    Lung Cancer; 2002 Nov; 38 Suppl 2():S13-9. PubMed ID: 12431824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current status and future directions of gemcitabine in the treatment of non-small cell lung cancer and pancreatic cancer].
    Yokoyama A
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1294-300. PubMed ID: 10945029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of non-small cell lung cancer in elderly patients.
    Gridelli C; Maione P; Colantuoni G; Rossi A
    Curr Med Chem; 2002 Aug; 9(16):1487-95. PubMed ID: 12171559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: preclinical and early clinical data.
    Reboul FL
    Hematol Oncol Clin North Am; 2004 Feb; 18(1):41-53. PubMed ID: 15005280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine and paclitaxel combinations in non-small cell lung cancer.
    Dombernowsky P; Giaccone G; Sandler A; Schwartsmann G
    Semin Oncol; 1998 Aug; 25(4 Suppl 9):44-50. PubMed ID: 9728584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction chemotherapy with gemcitabine and cisplatin in stage III non-small cell lung cancer.
    Rinaldi M; Crinò L
    Lung Cancer; 2001 Dec; 34 Suppl 4():S25-30. PubMed ID: 11742699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there any impact of new drugs on the outcome of advanced NSCLC? An overview of the Southern Italy Cooperative Oncology Group trials.
    Frasci G; Panza N; Comella G; Pacilio G
    Oncologist; 1999; 4(5):379-85. PubMed ID: 10551554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.